Protein crystallization and structure determination at room temperature in the CrystalChip.

Autor: Pachl P; CNRS, Architecture et Réactivité de l'ARN, UPR 9002, Institut de Biologie Moléculaire et Cellulaire, Université de Strasbourg, France.; Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Praha 6, Czech Republic., Coudray L; CNRS, Architecture et Réactivité de l'ARN, UPR 9002, Institut de Biologie Moléculaire et Cellulaire, Université de Strasbourg, France.; CNRS, Institut de Biologie Moléculaire et Cellulaire, UPR 2357, Université de Strasbourg, France., Vincent R; CNRS, Architecture et Réactivité de l'ARN, UPR 9002, Institut de Biologie Moléculaire et Cellulaire, Université de Strasbourg, France., Nilles L; CNRS, Architecture et Réactivité de l'ARN, UPR 9002, Institut de Biologie Moléculaire et Cellulaire, Université de Strasbourg, France., Scheer H; CNRS, Institut de Biologie Moléculaire et Cellulaire, UPR 2357, Université de Strasbourg, France., Ritzenthaler C; CNRS, Institut de Biologie Moléculaire et Cellulaire, UPR 2357, Université de Strasbourg, France., Fejfarová A; Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Praha 6, Czech Republic., Řezáčová P; Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Praha 6, Czech Republic., Engilberge S; CNRS, CEA, Institut de Biologie Structurale (IBS), Université Grenoble Alpes, France., Sauter C; CNRS, Architecture et Réactivité de l'ARN, UPR 9002, Institut de Biologie Moléculaire et Cellulaire, Université de Strasbourg, France.

Publikováno v: FEBS open bio [FEBS Open Bio] 2024 Nov 21. Date of Electronic Publication: 2024 Nov 21.

Noninvasive Monitoring of Mantle Cell Lymphoma by Immunoglobulin Gene Next-Generation Sequencing in a Phase 2 Study of Sequential Chemoradioimmunotherapy Followed by Autologous Stem-Cell Rescue

Autor: Kumar, Anita, Bantilan, K.S., Jacob, A.P., Park, A., Schoninger, S.F., Sauter, C., Ulaner, G.A., Casulo, C., Faham, M., Kong, K.A., Grewal, R.K., Gerecitano, J., Hamilton, A., Hamlin, P., Matasar, M., Moskowitz, C.H., Noy, A., Palomba, M.L., Portlock, C.S., Younes, A., Willis, T., Zelenetz, A.D.

Publikováno v: In Clinical Lymphoma, Myeloma and Leukemia April 2021 21(4):230-237

ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome.

Autor: Goyal A; Department of Dermatology, University of Minnesota, Minneapolis, Minnesota. Electronic address: Goyal046@umn.edu., O'Leary D; Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota., Dabaja B; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Weng WK; Blood and Marrow Transplantation, and Cellular Therapy, Department of Medicine, Stanford University, Stanford, California., Zain J; Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California., Cutler C; Division of Transplantation and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts., Guitart J; Department of Dermatology, Northwestern Feinberg School of Medicine, Evanston, Illinois., Kim YH; Departments of Dermatology and Medicine/Division of Oncology, Stanford University, Stanford, California., Geskin LJ; Department of Dermatology, Columbia University, New York, New York., Hoppe RT; Department of Radiation Oncology, Stanford University, Stanford, California., Wilson LD; Department of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut., Beaven AW; Division of Hematology, University of North Carolina, Chapel Hill, North Carolina., Horwitz S; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, New York., Allen PB; Department of Hematology & Medical Oncology, Emory University Winship Cancer Institute, Atlanta, Georgia., Barta SK; Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Bohjanen K; Department of Dermatology, University of Minnesota, Minneapolis, Minnesota., Brammer JE; Division of Hematology, Ohio State University James Comprehensive Cancer Center, Columbus, Ohio., Carter JB; Department of Dermatology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire., Comfere N; Departments of Dermatology and Laboratory Medicine & Pathology, Mayo Clinic, Rochester, Minnesota., DeSimone JA; Department of Dermatology, University of Virginia Schar Cancer Institute, Fairfax, Virginia., Dusenbery K; Department of Radiation Oncology, University of Minnesota, Minneapolis, Minnesota., Duvic M; Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas., Huen A; Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas., Jagadeesh D; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio., Kelsey CR; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina., Khodadoust MS; Division of Oncology, Department of Medicine, Stanford University, Stanford, California., Lechowicz MJ; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia., Mehta-Shah N; Department of Medicine, Division of Oncology, Washington University School of Medicine in St. Louis, St. Louis, Missouri., Moskowitz AJ; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, New York., Olsen EA; Departments of Dermatology and Medicine, Duke University Medical Center, Durham, North Carolina., Poh C; Division of Hematology and Oncology, University of Washington, Seattle, Washington., Pro B; Department of Hematology and Oncology, New York Presbyterian - Columbia University Irving Medical Center, New York, New York., Querfeld C; Department of Pathology, Division of Dermatology & Beckman Research Institute, City of Hope National Medical Center, Duarte, California., Sauter C; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio., Sokol L; Malignant Hematology, Moffitt Cancer Center, Tampa, Florida., Sokumbi O; Departments of Dermatology and Laboratory Medicine & Pathology, Mayo Clinic, Jacksonville, Florida., Wilcox RA; Division of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan., Zic JA; Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee., Hamadani M; Division of Hematology & Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin., Foss F; Department of Hematology/Oncology, Yale University School of Medicine, New Haven, Connecticut.

Publikováno v: Transplantation and cellular therapy [Transplant Cell Ther] 2024 Nov; Vol. 30 (11), pp. 1047-1060. Date of Electronic Publication: 2024 Sep 01.

The effect of exposure to radiofrequency electromagnetic fields on cognitive performance in human experimental studies: Systematic review and meta-analyses.

Autor: Pophof B; Federal Office for Radiation Protection, Competence Centre EMF, Oberschleißheim, Germany. Electronic address: bpophof@bfs.de., Kuhne J; Federal Office for Radiation Protection, Competence Centre EMF, Oberschleißheim, Germany., Schmid G; Seibersdorf Laboratories, Seibersdorf, Austria., Weiser E; Federal Office for Radiation Protection, Competence Centre EMF, Cottbus, Germany., Dorn H; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Competence Centre of Sleep Medicine, 12203 Berlin, Germany., Henschenmacher B; Federal Office for Radiation Protection, Optical Radiation, Oberschleißheim, Germany., Burns J; Institute for Medical Information Processing, Biometry and Epidemiology (IBE), LMU Munich, Germany., Danker-Hopfe H; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Competence Centre of Sleep Medicine, 12203 Berlin, Germany., Sauter C; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Competence Centre of Sleep Medicine, 12203 Berlin, Germany.

Publikováno v: Environment international [Environ Int] 2024 Sep; Vol. 191, pp. 108899. Date of Electronic Publication: 2024 Jul 22.

Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T-cell therapy: A CIBMTR analysis.

Autor: Epperla N; Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, Ohio, USA., Hashmi H; Adult Bone Marrow Transplant Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Ahn KW; Division of Biostatistics, Medical College of Wisconsin, Institute for Health and Equity, Milwaukee, Wisconsin, USA.; CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Allbee-Johnson M; CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Chen AI; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA., Wirk B; Bone Marrow Transplant Program, Penn State Cancer Institute, Hershey, Pennsylvania, USA., Kanakry JA; Center for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Lekakis L; Division of Transplantation and Cellular Therapy, Sylvester Comprehensive Cancer Center, University of Miami Hospital and Clinics, Miami, Florida, USA., Kharfan-Dabaja MA; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Mayo Clinic, Jacksonville, Florida, USA., Scordo M; Adult Bone Marrow Transplant Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Riedell PA; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, Illinois, USA., Jain T; Division of Hematological Malignancies and Blood or Marrow Transplantation, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA., Shadman M; Fred Hutchinson Cancer Center, University of Washington Medical Center, Seattle, Washington, USA., Sauter C; Department of Medicine, Cleveland Clinic, Cleveland, Ohio, USA., Hamadani M; CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, Wisconsin, USA.; BMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Herrera AF; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA., Ahmed S; Department of Lymphoma/Myeloma and Stem Cell Transplantation, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Publikováno v: British journal of haematology [Br J Haematol] 2024 Sep; Vol. 205 (3), pp. 1202-1207. Date of Electronic Publication: 2024 May 26.